Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Lombard Medical tables U.S. IPO
Lombard Medical Technologies said today that it’s tabling a planned initial public offering on the NASDAQ exchange due to adverse conditions in the U.S. stock market.
Lombard, which makes stent grafts to repair abdominal aortic aneurysms, said in late March that it would offer 3.6 million shares at $15-$18 apiece, aiming to raise between $55 million and $60 million from the IPO. Read more
2. FDA expands indication for Medtronic pacemakers, defibs
Medtronic said the FDA expanded the indication for some of its cardiac rhythm management devices to include bi-ventricular pacing in certain heart failure patients.
The FDA nod for Medtronic’s cardiac resynchronization therapy-pacemakers and cardiac resynchronization therapy-defibrillators is for patients with atrioventricular block and left ventricular systolic dysfunction, according to a press release. Read more
1. Covidien recalls Pipeline, Alligator brain aneurysm devices
Covidien said it’s recalling some of its Pipeline and Alligator brain embolism devices after internal testing revealed a potentially lethal problem with the guidewires used to deliver them.
Mansfield, Mass.-based Covidien said it hasn’t received any reports of injuries related to the problem, in which the plastic coating applied to the guidewire can delaminate and detach from the devices. The coating, made of polytetrafluoroethylene, is designed to reduce friction between the devices and the guidewire, according to a press release. Read more